AIkido Pharma Reports Cash, Cash Investments $104M+ For Q3, Provides Updates On Other Highlights From Last Qtr.
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today announced its third quarter ending September 30, 2021, financial highlights and provided a corporate update.
Highlights
Cash
Trump-Linked SPAC Has Traders Also Focused On These 6 Stocks
The second half of October has been one of the most active periods for the stock market in quite some time.
HC Wainwright & Co. Initiates Coverage On AIkido Pharma with Buy Rating, Announces Price Target of $2
HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on AIkido Pharma (NASDAQ:AIKI) with a Buy rating and announces Price Target of $2.
Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications
Photo by Joshua Mayo on Unsplash
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Geovax Labs (NASDAQ:GOVX) shares rose 46.37% to $6.06 during Tuesday's after-market session. This security traded at a volume of 1.9 million shares come close, making up 75.3% of its average volume over the last 100 days. The company's market cap stands at $38.3 million.
DatChat Shares Up ~19% To New Session High At $13.88; BZ NOTE: AIkido Pharma Shares Up ~14% Tuesday, Co. Owns 525K Shares Of DatChat (Disclosed In Sept. 14, 2021 Press Release From AIkido
https://www.prnewswire.com/news-releases/aikido-pharma-releases-shareholder-update-near-term-catalysts-approaching-301376188.html
AIkido Pharma Says Secures Interest In Electric Truck Maker, Tevva Motors; Terms Not Disclosed
AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today announced that the Company secured an equity interest in Tevva Motors Ltd, an electric truck producer with range extended